Product Description
Overall, the global intramedullary hip screw market was valued at $1.1 billion in 2021. This is expected to increase over the forecast period at a CAGR of 3.4% to reach $1.4 billion.
The full report suite on the global market for intramedullary (IM) hip screws includes titanium and stainless steel intramedullary hip screws.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2028, and Historical Data to 2018
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In 2021, the global intramedullary hip screw market increased in terms of the number of procedures performed. In 2020, the market saw a decrease in the procedure volume as a result of the COVID-19 pandemic. However, in 2021, the procedure numbers recovered to near pre-pandemic levels.
GLOBAL INTRAMEDULLARY HIP SCREW MARKET TRENDS
The IM hip screw has trended towards becoming more popular than conventional hip screws for treating hip fractures. Surgeons value the stability, rigidity and reliability offered by intramedullary hip screws, which is expected to lead to future growth.
GLOBAL INTRAMEDULLARY HIP SCREW MARKET SHARE INSIGHTS
Overall, within the global intramedullary hip screw market there are three dominant competitors: Stryker, DePuy Synthes, and Smith & Nephew.
The leading competitor in the intramedullary hip screw market was Stryker. The company boasts over 20 years of intramedullary hip screw experience, with some of the most trusted and used products on the market.
GLOBAL INTRAMEDULLARY HIP SCREW MARKET SEGMENTATION SUMMARY
- Titanium Intramedullary Hip Screws
- Stainless Steel Intramedullary Hip Screws
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2021 |
| Forecast Period | 2022-2028 |
| Historical Data | 2018-2021 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE iDATA?
-
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
